The Vanguard Group 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:17 pm Purchase | 2023-12-29 | 13G | Viridian Therapeutics, Inc. VRDN | The Vanguard Group | 3,000,948 5.710% | 885,954 (+41.89%) | Filing |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | Viridian Therapeutics, Inc. VRDN | The Vanguard Group | 2,114,994 5.250% | 2,114,994 (New Position) | Filing |